Evidence map›Paper›PMID 41287196›Full record

ArticleBJOG : an international journal of obstetrics and gynaecology2026

Assessing the Accuracy of Large Language Models on European Guidelines for Cervical Cancer: An In Silico Benchmarking Study.

Matteo Pavone, Chiara Innocenzi, Nicola Macellari, Chiara Cantarini, Massimo Criscione, Andrea Rosati, Lise Lecointre, Antonella Carcagnì, Barbara Costantini, Jacques Marescaux and 5 more

Abstract readComparative Study
In one paragraph

Article in BJOG : an international journal of obstetrics and gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Matteo PavoneUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-9791-9464
Chiara InnocenziUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Nicola MacellariUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Chiara CantariniUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Massimo CriscioneUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Andrea RosatiUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Lise LecointreInstitute of Image-Guided Surgery, IHU Strasbourg, Strasbourg, France.
Antonella CarcagnìFacility of Epidemiology and Biostatistics - Gemelli Generator, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Barbara CostantiniUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Jacques MarescauxResearch Institute Against Digestive Cancer, IRCAD Strasbourg, Strasbourg, France.
Anna FagottiUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Francesco FanfaniUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
David CibulaDepartment of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czechia.
Denis QuerleuUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Nicolò BizzarriUOC Ginecologia Oncologica, Dipartimento di Scienze per la Salute Della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-1727-904X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough large language models are increasingly used in clinical and research settings, the validity of the information they provide remains uncertain. This study aimed to evaluate the accuracy, consistency, and reliability of three large language models-ChatGPT 4.0, DeepSeek R1, and Gemini 2.0-in answering cervical cancer-related questions based on the ESGO/ESTRO/ESP guidelines.

designProspective, comparative in silico benchmarking study.

settingFondazione Policlinico Universitario A. Gemelli, Rome, Italy. POPULATION OR SAMPLE: Fifty questions derived from the ESGO/ESTRO/ESP (European Society of Gynaecologic Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology) Guidelines for Cervical Cancer.

methodsEach question was submitted simultaneously to ChatGPT 4.0, DeepSeek R1, and Gemini 2.0, and re-entered twice to assess response repeatability. Answers were evaluated for accuracy using a Global Quality Score (GQS) from 1 (poor) to 5 (completely accurate). Consistency (intra-model response stability) and reliability (alignment with guidelines) were assessed using binary classification.

main outcome measuresMedian GQS, percentage of GQS 5 responses, consistency between repeated answers, and reliability.

resultsChatGPT 4.0 achieved the highest performance, with 42% of responses rated GQS 5, followed by Gemini 2.0 (30%) and DeepSeek R1 (28%). DeepSeek R1 and Gemini 2.0 scored lower in median GQS (3.50) compared to ChatGPT 4.0 (4.00). Response consistency varied significantly, with ChatGPT 4.0 and DeepSeek R1 showing differences from Gemini 2.0 (p = 0.034 and p = 0.044, respectively). No significant difference was observed in reliability (p = 0.602).

conclusionAll models demonstrated suboptimal accuracy in aligning with clinical guidelines. ChatGPT 4.0 was the most accurate and consistent whereas DeepSeek R1 underperformed. Despite similar reliability across models, expert oversight remains essential to ensure safe clinical application and prevent misinformation.

Indexed as

LanguagePractice Guidelines as TopicUterine Cervical NeoplasmsBenchmarkingComputer SimulationEuropeFemaleHumansLarge Language ModelsProspective StudiesReproducibility of ResultsSurveys and Questionnairesartificial intelligencecervical cancerchatgptdeepseekdigital surgerygeminilarge language models

Identifiers

PMID41287196
PMCPMC12884235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.